MediWound Ltd. (MDWD) Receives Consensus Analysts Rating of ‘Buy’
MediWound Ltd. (NASDAQ: MDWD) is a biopharmaceutical company in the business of developing, manufacturing, and globally commercializing products that treat…
MediWound Ltd. (NASDAQ: MDWD) is a biopharmaceutical company in the business of developing, manufacturing, and globally commercializing products that treat…
As an eventful year for Globus Medical, Inc. (NYSE: GMED) is nearing an end, the leading medical device company experienced…
Investing in publicly traded companies is much easier than what it used to be. Now you can sign up for…
Intellipharmaceutics International, Inc. (NASDAQ: IPCI) is a pharmaceutical company in the business of researching, developing, and manufacturing new and generic…
Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company focused on the development, commercialization, and manufacture of botulinum toxin products for…
Now that residents of the Golden State have approved Proposition 64, California joins the District of Columbia and the states…
The Trade Desk, Inc. (NASDAQ: TTD) is a technology company that allows buyers to use proprietary data to better target…
On December 1, 2016, OurPet’s Company (OTCQX: OPCO) gave an investor presentation with VirtualInvestorConferences.com (powered by PR Newswire), in which…
Before the opening bell, NetworkNewsWire (NNW), a multifaceted financial news and publishing company that delivers a new generation of social…
Daktronics, Inc. (NASDAQ: DAKT), a company that designs, manufactures, and sells electronic display systems and related products on a global…